Biotech

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets

DUBLIN, IRELAND: U.S. Patent Scheduled to Issue Provides VIMOVO Patent Protection to 2030 ...

Corbus Pharmaceuticals to Present at the Leerink Partners Rare Disease Roundtable in New York on Wednesday, October 1, 2014

NORWOOD, MA: ...

Critical Outcome Technologies'' First Quarter Marked by Key Developments for COTI-2

LONDON, ONTARIO: Development of lead cancer drug candidate gaining momentum toward the clinic ...

Benchworks Collaborates With Boston Therapeutics to Market sugardown(R)

CHESTERTOWN, MD: Launches the Commercialization Phase of sugardown(R) in North America ...

Horizon Pharma plc Announces Management Executive Committee and Commercial Restructuring Following Close of Acquisition of Vidara Therapeutics International plc

DUBLIN, IRELAND: Elizabeth M. Higashi, CFA Appointed Vice President, Investor Relations ...

Miraculins Receives First Payment Under Sales and Distribution Agreement for Scout DS® Diabetes Screening Devices in China

WINNIPEG, MANITOBA: ...

Cambridge Healthtech Institute Announces the Acquisition of OpenHelix

NEEDHAM, MA: Provider of Online and Onsite Bioinformatics Training to Join Cambridge Healthtech Institute as Division of Bio-IT World ...

Calyx Enters Into Definitive Agreements To Acquire Cannigistics Agri-Solutions Corp.

VANCOUVER, BRITISH COLUMBIA: ...

Horizon Pharma plc to Host Friedreich''s Ataxia Analyst Day on October 13, 2014

DUBLIN, IRELAND: ACTIMMUNE(R) (Interferon gamma-1b) Phase 2 Results in Friedreich's Ataxia to Be Presented ...

Monitoring Branded Label Changes Effectively to Ensure Proper Generic Label Documentation, Compliance and Safety

PHILADELPHIA, PA: Inviting Heads, VPs, Directors, Managers, and Specialists of Labeling and Regulatory Affairs From Leading Pharmaceutical and Biotech Companies to Discuss Best Practices for Generic Label Documentation ...